Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Bristol Discontinues Serzone, Stadol And 15 Other Brands; Safety In Numbers?

May 24 2004

• By The Pink Sheet

Related Content

Bristol Serzone Status Unchanged In U.S.; Antidepressant Pulled In Europe

Jan 13 2003

FDA Opioid Analgesics Risk Management Models Include Stadol NS, Actiq

Sep 24 2001

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window